US Patent Litigations are now available. Check here

Explore Uniqure Biopharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP4032979May 1, 2024Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production1
EP3581650Dec 28, 2022Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production1
EP2337849Jun 13, 2018Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production5